- Global Pharma News & Resources

Global Parkinson’s Disease (PD) Drugs Market Business Outlook 2022: Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries

Pune, Maharashtra, India, November 8 2022 (Wiredrelease) –:Major players operating in the Global Parkinson’s Disease (PD) Drugs Market include Boehringer Ingelheim, GlaxoSmithKline, Novartis, Teva Pharmaceutical Industries, AbbVie, Abital Pharma, Addex Therapeutics, Biogen, Eisai, Eli Lilly, F. Hoffmann-La Roche, H. Lundbeck, Impax Laboratories, Kyowa Hakko Kirin, Otsuka Pharmaceutical, Pfizer.

Market Size, Type, Applications, Key Players, Analysis, Demand, Share, Price, Trend, and Forecast is a professional and in-depth study on the current state of the Global Parkinson’s Disease (PD) Drugs Industry. It is estimated to be US$ 5651 million in 2022 and is forecast to a readjusted size of USD 8374.4 million by 2029 and is projected to grow at a CAGR of 5.8%. The report analyses the global Parkinson’s Disease (PD) Drugs market growth, as well as the major market participants.

Sample Copy of Parkinson’s Disease (PD) Drugs Market Report @

Parkinson’s disease (PD), a progressive and chronic movement disorder, affects around one million Americans. There are many PD drugs that can be used to treat the symptoms of Parkinson’s disease. Levodopa and dopamine agonists are some of the most commonly used PD drugs. These PD drugs can improve motor symptoms associated with Parkinson’s disease through increasing brain dopamine levels.

Dopamine is a chemical that increases brain levels or mimics its effects. Most Parkinson’s disease drugs (PD) work by increasing brain levels. Dopamine, also known as a neurotransmitter is a chemical messenger that relays signals between brain cells. PD occurs when nerve cells die in the substantia nigra, an area of brain. Dopamine is produced in these nerve cells. These cells eventually die and the brain loses more dopamine. This causes PD symptoms. Levodopa and carbidopa–levodopa are drugs that increase dopamine levels. These drugs may help with PD symptoms like tremor, rigidity and slowness in movement. They can also cause nausea, vomiting and dizziness.

This report offers an in-depth view of market opportunity by user segments, product segments, sales channels, key countries, and import-export dynamics. Parkinson’s Disease (PD) Drugs industry report analyzes the market size, growth drivers, rising trends, market opportunities, forecast, and investment risks in over varied segments in Parkinson’s Disease (PD) Drugs business. It provides a comprehensive understanding of Parkinson’s Disease (PD) Drugs market dynamics in each value and volume term.

Region Coverage (Regional Production, Demand & Forecast by Countries, etc.):

– North America (U.S., Canada, Mexico)

– Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

– Asia-Pacific (China, India, Japan, Southeast Asia etc.)

– South America (Brazil, Argentina etc.)

This report segments the Global Parkinson’s Disease (PD) Drugs Market on the basis of Types are:

Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors

On the basis of Application, the Global Parkinson’s Disease (PD) Drugs Market is segmented into:


Global Parkinson’s Disease (PD) Drugs report examines the advancement opportunities of the market, business strategies, deals volume and most recent improvements occurring in Parkinson’s Disease (PD) Drugs industry. Details such as the product launch, industry news, development drivers, difficulties and speculation scope have been analyzed at profundity in Parkinson’s Disease (PD) Drugs research report.

In this study, the years considered to estimate the market size of Parkinson’s Disease (PD) Drugs are as follows:

History Year: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Year : 2022 to 2029

Link For Buying Report @

There are 15 Chapters to display the Global Parkinson’s Disease (PD) Drugs market

Chapter 1, Definition, Specifications and Classification of Parkinson’s Disease (PD) Drugs , Applications of Parkinson’s Disease (PD) Drugs , Market Segment by Regions;

Chapter 2, Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;

Chapter 3, Technical Data and Manufacturing Plants Analysis of Parkinson’s Disease (PD) Drugs , Capacity and Commercial Production Date, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis;

Chapter 4, Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);

Chapter 5 and 6, Regional Market Analysis that includes United States, China, Europe, Japan, Korea & Taiwan, Parkinson’s Disease (PD) Drugs Segment Market Analysis (by Type);

Chapter 7 and 8, The Parkinson’s Disease (PD) Drugs Segment Market Analysis (by Application) Major Manufacturers Analysis of Parkinson’s Disease (PD) Drugs ;

Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type , Market Trend by Application ;

Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;

Chapter 11, The Consumers Analysis of Global Parkinson’s Disease (PD) Drugs ;

Chapter 12, Parkinson’s Disease (PD) Drugs Research Findings and Conclusion, Appendix, methodology and data source;

Chapter 13, 14 and 15, Parkinson’s Disease (PD) Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Browse Our Top Reports:

Global Recent Research Report on Co-Living Market:

Global Carbon Black Feedstock Oil Market:

Global Baby Diaper Rash Cream Market:

Global UPS Battery Market:

Global Modular Kitchen and Wardrobe Cabinet Market:

Get in touch with Us:

Tel No: +1 (857) 445 0045



Blog: marketbusinesspr

This content has been published by company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 08-Nov-2022